Respiratory Drug News

出版商	Espicom Business Intelligence
出版日期		商品編碼	66835
內容資訊	英文
價格	US $ 690 1 Year Web Access (Single User License)

簡介
目錄
相關商品

Respiratory Drug News 是由出版商Espicom Business Intelligence在出版的。這份英文新聞出版品價格從美金690起跳。

簡介

呼吸器官疾病中最大市場區隔的氣喘病全球市場規模推算有150億美元。另一方面，慢性閉鎖性肺部疾疾（COPD）的市場規模目前雖只有40至50億美元，但正在快速成長當中，預計未來5年內市場規模將成長至2倍以上。

本新聞資料內容包括Espicom公司的研究人員及編輯透過企業・研究機構、會議等蒐集的呼吸器官疾病治療藥相關最新新聞，透過網路即時提供。

提供内容

所有種類的呼吸器官疾病治療藥及其開發動向等相關最新新聞全文
方便取得最新資訊的界面
包括2,116則以上報導的廣泛內容資料庫
迅速且高效率的搜尋功能
每日&每週電子郵件通知
RSS訂閱功能

The largest respiratory sector, asthma, is valued at around US$15 billion globally. The COPD market is valued at US$4-5 billion, but is fast growing and expected to double in the next five years. Future market growth will be driven by increasing disease awareness, an increasing patient pool, both in the paediatric asthma sector and the ageing population susceptible to COPD, and the launch of newer, more expensive therapies targeting areas of high unmet clinical need. These will be offset to some extent by the launch of new generics and the erosion of monotherapy product sales by combination drugs.

For pharmaceutical company executives, researchers and commercial managers, this sector is taking an important role in the industry' s plans; staying in touch with the latest twists and turns, however, is another matter. That is why this new, daily-updated online information service is essential.

Respiratory Drugs News provides:

The full text of the latest news reported on all types of respiratory drugs and their development
An easy-to-use interface that immediately takes you to the most recently updated information
An extensive archive of over 2,116 articles which makes the service a valuable tracking and research tool
A fast and effective search facility allowing you to identify information relevant to your needs
Daily or weekly email alerts which will ensure you know when new information is added
An RSS feed facility